Subscribe for email alerts

Don’t miss a single Science & Enterprise post. Sign up for our daily email alerts.

Donate to Science & Enterprise

Please share Science & Enterprise

Company Formed to Boost Clinical Trial Success Odds

Human machine interface

A pharma/tech industry group is starting a new company to use algorithms for finding gaps in preclinical data that can impair clinical trial progress. . . . → Read More: Company Formed to Boost Clinical Trial Success Odds

Start-Up Licenses Gene-Edited Drug Discovery Tech.

African clawed frog

A new company is acquiring a technology using genome-edited tadpoles that finds current drugs addressing precise genetic conditions underlying rare diseases. . . . → Read More: Start-Up Licenses Gene-Edited Drug Discovery Tech.

NIH Funds Decentralized Rare Disease Data Network

Blockchain

A start-up company is building a secure decentralized network of genomic and other medical data on rare diseases, funded by a fast-track award from an NIH agency. . . . → Read More: NIH Funds Decentralized Rare Disease Data Network

Trial Underway Assessing Gut Microbiome-Cancer Links

Gut microbes

A clinical trial began collecting stool and blood samples to find connections between microbial communities in the gut and four types of solid-tumor cancer. . . . → Read More: Trial Underway Assessing Gut Microbiome-Cancer Links

Infographic – Smart Home Technologies Emerge

Chart: Smart home technologies

While these systems promise a more connected, efficient, and pleasant home, they require continued development of underlying basic technologies. . . . → Read More: Infographic – Smart Home Technologies Emerge

Gut Microbes Shown to Detect Colorectal Cancer

Detect cancer scrabble

An analysis of gut bacteria and blood samples from patients indicates changes in the microbiome can provide early warnings for colorectal cancer. . . . → Read More: Gut Microbes Shown to Detect Colorectal Cancer

Precision Meds Shown Effective in Rare Cancer

Cancer on clipboard

Results from a clinical trial show patients with rare bile duct tumors respond to an experimental treatment blocking a specific cancer-causing protein. . . . → Read More: Precision Meds Shown Effective in Rare Cancer

Trial to Assess Multi-Factor Blood Test for Cancer

Blood sample vials

A clinical trial is set to begin that evaluates genomic and related data from routine blood tests to screen for cancer in real-world settings. . . . → Read More: Trial to Assess Multi-Factor Blood Test for Cancer

AI Recreates Tumor Environment for Precision Cancer Care

Breast tumor microenvironment

A bioinformatics company designed an algorithm that digitally recreates the support network for tumors from RNA sequences, to guide precise treatments for cancer patients. . . . → Read More: AI Recreates Tumor Environment for Precision Cancer Care

Synthetic Bio Chemicals Start-Up Gains $5M in Early Funds

Brewer's yeast

A new enterprise using digital and synthetic biology to create sustainable chemicals at industrial scale is raising $5 million in pre-seed round funds. . . . → Read More: Synthetic Bio Chemicals Start-Up Gains $5M in Early Funds